1
Dupilumab-PEdiatric Skin Barrier Function and LIpidomics STudy in Patients With Atopic Dermatitis
Condition(s):Dermatitis AtopicLast Updated:February 21, 2021Recruiting
Dupilumab SAR231893: 59 Clinical Trials, Page 1 of 6
Hide Studies Not Open or Pending
2
Description of Characteristics, Such as Age, Previous and Concurrent Treatments, Associated Diseases, of Patients With Asthma Treated With Dupilumab (DUPIXENT)
Condition(s):AsthmaLast Updated:January 5, 2021Recruiting
3
Dupilumab Skin Barrier Function Study in Atopic Dermatitis
Condition(s):Atopic DermatitisLast Updated:February 5, 2021Active, not recruiting
4
Observational Study of Adult Patients Receiving Dupixent® for Atopic Dermatitis (AD)
Condition(s):Dermatitis AtopicLast Updated:February 11, 2021Recruiting
5
Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety in Patients With Asthma (Long-Term Follow-Up)
Condition(s):AsthmaLast Updated:September 9, 2020Active, not recruiting
6
Dupilumab in CRSsNP
Condition(s):Chronic Rhinosinusitis Without Nasal PolypsLast Updated:January 22, 2021Recruiting
7
Dupilumab in Allergic Fungal Rhinosinusitis (AFRS)
Condition(s):Allergic Fungal RhinosinusitisLast Updated:January 6, 2021Recruiting
8
The Effect of Dupilumab on Lung Function and Related Changes in Airway Volumes Detectable by Functional Respiratory Imaging in Patients With Moderate-severe Asthma
Condition(s):AsthmaLast Updated:February 24, 2021Recruiting
9
Dupilumab in Japanese Patients With Atopic Dermatitis
Condition(s):Atopic DermatitisLast Updated:January 22, 2021Recruiting
10
Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS)
Condition(s):Cold UrticariaLast Updated:January 26, 2021Recruiting